Jeena Sikho Lifecare Limited has received National Accreditation Board for Hospitals & Healthcare Providers (NABH) accreditation for its Noida hospital facility. The company announced this development to stock exchanges on April 15, 2026, under Regulation 30 of SEBI listing requirements.

Accreditation Details

The NABH certification covers specific services and operational parameters at the company's Noida facility:

Significance of NABH Accreditation

The receipt of NABH accreditation represents adherence to nationally recognized standards across multiple operational areas. The certification validates the hospital's commitment to quality healthcare delivery, patient safety protocols, and operational excellence. NABH accreditation is considered a benchmark for healthcare institutions in India, ensuring compliance with established quality parameters.

Business Impact

Jeena Sikho Lifecare clarified that this accreditation occurred in the ordinary course of business operations. The company specifically noted that this development does not constitute business expansion, capacity enhancement, or acquisition activities. The accreditation applies to the existing Panchakarma services at the Noida facility.

Company Operations

Jeena Sikho Lifecare operates over 120 Ayurveda clinics and hospitals across its network. The company's registered office is located in Zirakpur, Punjab, while its corporate office operates from New Delhi. The Noida facility represents part of the company's existing healthcare infrastructure focused on traditional Ayurvedic treatments and wellness services.

The accreditation information has been made available on the company's website at www.jeenasikho.com , providing stakeholders with access to certification details and validity periods.

Sat Kartar Life Limited has entered into a Strategic Memorandum of Understanding with Jeena Sikho Lifecare Limited on April 14, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The collaboration integrates Sat Kartar Life Limited's AI-driven patient acquisition ecosystem with Jeena Sikho Lifecare's clinical and institutional healthcare infrastructure to enhance efficiency, scalability, and patient outcomes.

Strategic Collaboration Framework

The MOU establishes a structured pipeline where patient identification, engagement, and funnelling are managed through Sat Kartar Life Limited's systems, while diagnosis, treatment, and healthcare delivery remain exclusively within the domain and control of Jeena Sikho Lifecare Limited. This arrangement ensures that clinical integrity is preserved and operational accountability remains clearly demarcated between the parties.

Revenue Sharing Structure

The agreement establishes a comprehensive revenue-sharing model where Sat Kartar Life Limited receives a percentage of billing values across different service categories from Jeena Sikho Lifecare Limited based on actual patient treatments and payments received.

The revenue share is payable only after actual payment is received from patients, with exclusions for leads, appointments, non-converted patients, GST, discounts, and free treatments. Monthly reconciliation and transparent reporting mechanisms are established, with audit rights retained by Jeena Sikho Lifecare Limited.

Future Development Plans

The MOU records Sat Kartar Life Limited's intention to develop Ayurveda hospitals and healthcare centres, including in South India. Under potential separate agreements, Jeena Sikho Lifecare Limited may provide operational and management services for such facilities, while Sat Kartar Life Limited will handle infrastructure, capital investment, statutory compliances, licensing, and setup.

Market Positioning and Compliance

The transaction does not fall within the definition of a Related Party Transaction under SEBI regulations, as Sat Kartar Life Limited and its promoters are not related to the promoters or promoter group of Jeena Sikho Lifecare Limited. No regulatory approvals are required at this stage, and the MOU does not create any partnership, joint venture, or agency relationship between the parties.

Key Terms and Digital Infrastructure

Under the collaboration framework, each party retains ownership of pre-existing data, while patient-related clinical data post consultation vests exclusively with Jeena Sikho Lifecare Limited. The parties will act as independent contractors, with Jeena Sikho Lifecare Limited maintaining responsibility and authority over clinical operations, medical protocols, treatment decisions, and patient care delivery in accordance with applicable medical and regulatory requirements.

The Board of Directors meeting to approve this MOU commenced at 8:30 P.M. (IST) and concluded at 9:30 P.M. (IST) on April 14, 2026, with Managing Director Manish Grover signing the disclosure documents.